Fenretinide (4-HPR): a preventive chance for women at genetic and familial risk?

Cazzaniga, Massimiliano

Fenretinide (4-HPR): a preventive chance for women at genetic and familial risk? [electronic resource] - Journal of biomedicine & biotechnology 2012 - 172897 p. digital

Publication Type: Journal Article; Review

1110-7251

10.1155/2012/172897 doi


Anticarcinogenic Agents--therapeutic use
Breast Neoplasms--genetics
Female
Fenretinide--therapeutic use
Genetic Predisposition to Disease
Humans
Ovarian Neoplasms--genetics